April 15, 2026 01:00 ET | Source: BioVersys BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature…
REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for…
PORTLAND, Ore., April 14, 2026 (GLOBE NEWSWIRE) -- As AI draws new attention to geometry, one challenge remains unresolved: turning…
Jama Connect once again recognized as the best requirements management software by G2's Grid® Methodology April 14, 2026 11:00 ET…
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- TRUEiGTECH today announced the launch of its unified prediction market platform API,…
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026QUVIVIQ®…
Company announcement no. 10 - 2614 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG…
April 14, 2026 03:30 ET | Source: Asgard Therapeutics Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s…
The 2026 State of HR Survey Highlights the Need for Streamlined HR Solutions in Small and Medium-Sized Businesses April 13,…
CHICAGO, April 13, 2026 (GLOBE NEWSWIRE) -- Datatruck, the AI-native transportation management system (TMS) for carriers and freight brokers, today…